Health ❯Pharmaceuticals ❯Weight Loss Drugs

Wegovy

Novo Nordisk Zepbound Demand Market Competition Consumer Safety Hims & Hers Health Sales Growth Patient Safety

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition